Descent of pelvic organs through pelvic floor defects: cystocele, rectocele, enterocele, uterine.
Also known as: POP, cystocele, rectocele, uterine prolapse, vaginal prolapse, enterocele
Overview
Symptomatic descent of one or more of the anterior vaginal wall (cystocele), posterior vaginal wall (rectocele), uterus/apex, or vaginal vault (post-hysterectomy) through the pelvic floor. Severity is graded by the POP-Q (Pelvic Organ Prolapse Quantification) system.
Epidemiology
Lifetime risk of surgery for prolapse or incontinence ~13%. Prevalence increases with age and parity; nearly 50% of parous women have some degree of prolapse on examination but only a minority are symptomatic.
Try two board-style Pelvic Organ Prolapse questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1ReproductiveMedium
A 64-year-old G4P4 postmenopausal woman presents with a 6-month history of vaginal pressure and a sensation that 'something is falling out' that worsens with prolonged standing and improves when she lies down. She also reports needing to splint the posterior vaginal wall to complete bowel movements. She had four vaginal deliveries, the largest infant weighing 4,200 g. On pelvic examination with Valsalva, the cervix descends to 3 cm beyond the hymen without complete vaginal eversion. Which of the following is the most likely diagnosis?
AStage I uterine prolapse
BStage III uterine prolapse
CCystocele
DStage II uterine prolapse
Reveal answer & full explanation
Correct answer: B — Stage III uterine prolapse
AStage I uterine prolapse
BStage III uterine prolapse✓
CCystocele
DStage II uterine prolapse
Why Stage III uterine prolapse is correct
Pelvic organ prolapse is staged by the POP-Q system using the most distal point of the leading edge relative to the hymen.
Stage 0 = no descent; stage I = leading edge more than 1 cm above the hymen; stage II = leading edge within 1 cm of the hymen; stage III = leading edge more than 1 cm beyond the hymen without complete eversion; stage IV = complete eversion.
This patient's cervix descends to 3 cm beyond the hymen with bulge symptoms and obstructed defecation, placing the leading edge well beyond +1 cm and consistent with stage III.
Why the others are wrong
Stage I uterine prolapse — describes a leading edge more than 1 cm above the hymen and would not produce a visible bulge or symptoms; choosing it under-stages the obvious protrusion beyond the hymen.
Stage II uterine prolapse — describes a leading edge within 1 cm above or below the hymen; a cervix reaching 3 cm past the hymen lies well outside that window, so this under-stages the measured descent.
Cystocele — anterior vaginal wall prolapse from bladder descent; her posterior splinting may reflect a coexisting defect, but the leading point is the cervix, so anchoring on a compartment defect misses the primary uterine prolapse.
Question 2ReproductiveMedium
A 70-year-old G5P5 woman has stage II uterine prolapse with vaginal pressure on prolonged standing. She is sexually active, has well-controlled hypertension, type 2 diabetes, and prior CABG, and wishes to avoid surgery. Exam: cervix descends to the hymen with Valsalva and mild anterior wall descent. Which of the following is the most appropriate first-line management?
AVaginal pessary placement
BSystemic estrogen therapy
CTopical vaginal estrogen
DVaginal dilator therapy
Reveal answer & full explanation
Correct answer: A — Vaginal pessary placement
AVaginal pessary placement✓
BSystemic estrogen therapy
CTopical vaginal estrogen
DVaginal dilator therapy
Why Vaginal pessary placement is correct
First-line management of symptomatic pelvic organ prolapse in patients who wish to avoid surgery or have significant surgical risk is a vaginal pessary combined with pelvic floor muscle training
Pessaries are effective in 60-80% of patients, are reversible, and preserve sexual function with appropriate device selection (e.g., ring with or without support)
Why the others are wrong
Systemic estrogen therapy — systemic estrogen does not restore pelvic support and adds thromboembolic and cardiovascular risk in a woman with prior coronary bypass surgery
Topical vaginal estrogen — can improve tissue quality and is often used as adjunct therapy with a pessary but does not correct prolapse
Vaginal dilator therapy — dilators are used for vaginal stenosis and dyspareunia; they stretch the vaginal canal and provide no support for the descending cervix or anterior wall
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Pelvic Organ Prolapse outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Pelvic floor support depends on the levator ani musculature, endopelvic fascia, and uterosacral/cardinal ligament complex. Childbirth and aging weaken and stretch these structures, allowing descent of pelvic organs. Estrogen loss reduces collagen content of vaginal tissues.
Clinical presentation
Symptoms
Vaginal bulge or 'something falling out' — most specific symptom
Pelvic pressure or heaviness worsening with prolonged standing
Urinary symptoms: incomplete emptying, urgency, splinting (manual reduction to void), recurrent UTI
Bowel symptoms: incomplete defecation, need to splint the posterior vaginal wall or perineum to defecate, constipation
Sexual symptoms: dyspareunia, decreased sensation, embarrassment
Signs / physical exam
POP-Q assessment with patient in lithotomy and on Valsalva — describes leading edge of anterior, posterior, and apical compartments relative to the hymen
Stage 0 (no prolapse) to Stage IV (complete eversion)
Speculum or Sims retractor used to isolate compartments
Look for ulceration of exposed tissue in advanced prolapse
Differential diagnosis
Stress urinary incontinence — Leakage with cough/sneeze/Valsalva; may coexist with cystocele or be unmasked after prolapse repair
Urinary tract infection — Dysuria, frequency, urgency; UA positive
Vaginal mass (cyst, malignancy) — Discrete mass not reducible; biopsy if suspicious
Pelvic floor muscle training (Kegel exercises) +/- supervised physical therapy — may reduce symptoms in mild prolapse
Vaginal pessary — first-line nonsurgical management; fitted by trained clinician; many shapes (ring, Gellhorn, donut, cube); requires periodic cleaning and follow-up
Vaginal estrogen (estradiol cream or tablet, conjugated equine estrogen cream) in postmenopausal women to improve tissue quality and pessary tolerance
Surgical (when symptoms warrant and conservative measures fail)
Reconstructive: anterior or posterior colporrhaphy, apical suspension (uterosacral or sacrospinous ligament suspension; sacrocolpopexy — abdominal/laparoscopic, gold standard for apical prolapse)
Vaginal hysterectomy with apical suspension is common when uterine prolapse present
Obliterative (colpocleisis): for women who do not desire vaginal function; lower morbidity, very high success
Transvaginal synthetic mesh for prolapse repair was banned by FDA in 2019 due to high complication rates
Second-line / adjunct
Anti-incontinence procedure (midurethral sling) may be performed concurrently in selected patients with stress incontinence (occult or overt)
Complications
Vaginal ulceration and bleeding from advanced prolapse or ill-fitting pessary
Recurrent UTIs from incomplete emptying
Defecatory dysfunction and chronic constipation
Recurrence after surgical repair (~10-30% over 5 years)
Surgical complications: mesh erosion (with sacrocolpopexy), de novo dyspareunia, urinary or fecal incontinence
PANCE pearls
Pessaries are first-line for symptomatic prolapse — they are safe, effective in 60-80%, and avoid surgery; offer to all patients including those who desire future fertility.
Vaginal estrogen markedly improves tissue quality in postmenopausal women and is appropriate adjunct to either pessary or surgical management.
Stage of prolapse does not strictly determine the need for treatment — symptom burden and patient preference do.
Always inquire about hidden ('occult') stress incontinence after reducing prolapse, as some women develop new SUI postoperatively.
Transvaginal mesh for prolapse repair is no longer FDA-approved; mesh remains used in abdominal sacrocolpopexy and for midurethral slings, which have a different regulatory status.
References
ACOG PB 214 — ACOG Practice Bulletin 214: Pelvic Organ Prolapse (Obstet Gynecol 2019, reaffirmed)
AUGS — AUGS Position Statement on Vaginal Mesh (2019)
OPTIMAL Trial — Barber et al., JAMA 2014 — uterosacral vs sacrospinous suspension
Practice Reproductive questions on FirstPassPA
Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.